Pharmaceutical Business review

Radient files cancer test patent in China, Japan

Onko-Sure blood test kit is a 96-well Enzyme-linked immunosorbent assay (ELISA) which is used to detect and treat 19 different types of cancers.

Radient Pharmaceuticals chairman and CEO Douglas MacLellan said Japan and China are larger markets, where having patent protection improves their ability to forge productive distribution partnerships for their cancer test.